The listing below shows our latest News Items and is updated regularly. If you wish to post a news item please select the 'Post News' button on the right. The displayed news feed starts on 1st August 2016. Older items can be found here.
To 'Post Your News' use the button at the top right.
We are pleased to present below all posts archived in 'July, 2018'. If you still can't find what you are looking for, try using the search box.
AMSBIO has announced an exosome isolation, manufacturing and characterization service to enable R&D groups to accelerate their discovery and development activities.
Read the rest of entry »
AMSBIO has introduced new CRISPR / Cas9 editing kits for gene knock-out, gene knock-in and gene mutation applications.
Silence Therapeutics plc, a leader in the discovery and development of novel RNA therapeutics announces today the appointment of Dr David Horn Solomon as its new Chief Executive Officer (CEO) effective immediately. David will head the Leadership Team and joins the Board of Directors.
Wickham Laboratories is pleased to announce our latest article published by Cleanroom Technology, “Isolator sterility put to the test,” written by our Sterility Section Head, Stacey Orley.
ScreenIn3D (Glasgow, UK) is a new joint venture company set up by AMSBIO and the University of Strathclyde exploiting the latest advances in microfluidics and 3D culture to develop a novel microfluidic screening platform.
Isansys Lifecare wins Best Use of Technology award at the Thames Valley Chamber of Commerce Business Awards
Oxford, UK, July 5 2018 - The state-of-the-art Schrödinger Building at The Oxford Science Park, one of the UK's leading parks for science and technology companies, is to be opened this afternoon by Sam Gyimah MP, Minister of State for Universities, Science, Research & Innovation. Architecturally inspiring and built to promote collaboration and cross-fertilisation of ideas, the four-storey office and laboratory facility is part of the programme of investment on the Park which has been ongoing since 2016. The building is named after Professor Erwin Schrödinger, recipient of the Nobel Prize for Physics in 1933 and an alumnus of Magdalen College Oxford, which owns The Oxford Science Park.
As well as declaring the Schrödinger Building open, the Minister will hear about the work of 3D technology innovator Fuel3D and Oxford Sciences Innovation, its first two occupiers. A third occupant is expected to be announced shortly.
At 61,500 ft2 (net internal area), the £13m ...
You may be aware of the very tax advantaged form of share options known as Enterprise Management Incentives (EMI), which can result in an overall tax rate of 10% when employees or directors sell their shares arising from the share options; rather than at much higher income tax rates of at least 40% under different types of share options. Many technology companies use EMI options to supplement their remuneration and tie in key staff to the company.
There was an unfortunate break in the availability of these EMI options earlier in the year, when the Government missed the deadline for EU approval of them as a ‘state-aided’ tax advantage. This hiatus lasted from April until mid-May, but the necessary approval has now been given and companies are now free to grant further share options under the rules of the EMI scheme.
This is good news for any technology companies wanting to reward staff and senior management with shares in a tax-efficient way.
One important aspect of ...
'A Diamond does not start out polished and shining, but with enough pressure, hard work and time it becomes brilliant'
Kite Pharma secures breakthrough European positive opinion for CAR-T cell cancer therapy.
OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.